Changes in mean GS-C over time , FDS `` responder '' status defined as either 0.1 m/s gain in GS-C ( the minimal clinically important difference [ MCID ] ) or advancing by one Perry Ambulation Category ( PAC ) , and the incidence and nature of adverse events ( AEs ) .